Segmentectomy for Lung Adenocarcinoma: The Impact of EGFR Mutation Status on Recurrence

被引：0
|
作者：
Hyun, K. [1 ]
Park, S. [1 ]
Lee, H. J. [1 ]
Park, I. K. [2 ]
Kim, Y. [2 ]
Kang, C. H. [1 ]
机构：
[1] Seoul Natl Univ Hosp, Dept Thorac & Cardiovasc Surg, Seoul, South Korea
[2] Seoul Natl Univ Hosp, Thorac & Cardiovasc Surg, Seoul, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
segmentectomy; EGFR; Adenocarcinoma;
D O I：
10.1016/j.jtho.2017.09.1828
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.16-022
引用
收藏
页码：S2351 / S2351
页数：1
相关论文
共 50 条
  • [21] The effect of anticancer chemotherapeutics on immune microenvironment of lung adenocarcinoma with EGFR mutation in vivomicroenvironment of lung adenocarcinoma with EGFR mutation in vivo
    Suh, Young-Ah
    Mun, Hyemin
    Lee, Sun-Hye
    Jo, Se-Young
    Oh, Ju-Hee
    Lee, Chu-Hee
    CANCER RESEARCH, 2018, 78 (13)
  • [22] EGFR mutation signature in lung adenocarcinoma.
    Lamlertthon, Wisut
    Weiss, Jared
    Wilkerson, Matthew
    Hayward, Michele C.
    Hayes, David N.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [23] Diffuse Metastases of Lung Adenocarcinoma with EGFR mutation
    Kunimasa, Kei
    Masuda, Gen
    Watanabe, Naoki
    Ishida, Tadashi
    INTERNAL MEDICINE, 2012, 51 (06) : 685 - 686
  • [24] Spectrum of EGFR Mutation in Lung Adenocarcinoma in Morocco
    Leon, Larry Frank
    Day, Bann-Mo
    Hu, Xiaoping Sylvia
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (12) : e116 - e116
  • [25] Tissue heterogeneity of EGFR mutation in lung adenocarcinoma
    Sakurada, Akira
    Lara-Guerra, Humberto
    Liu, Ni
    Shepherd, Frances A.
    Tsao, Ming-Sound
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (05) : 527 - 529
  • [26] EGFR mutation and lobar location of lung adenocarcinoma
    Tseng, Chien-Hua
    Chen, Kun-Chieh
    Hsu, Kuo-Hsuan
    Tseng, Jeng-Sen
    Ho, Chao-Chi
    Hsia, Te-Chun
    Su, Kang-Yi
    Wu, Ming-Fang
    Chiu, Kuo-Liang
    Liu, Chien-Ming
    Wu, Tzu-Chin
    Chen, Hung-Jen
    Chen, Hsuan-Yu
    Chang, Chi-Sheng
    Hsu, Chung-Ping
    Hsia, Jiun-Yi
    Chuang, Cheng-Yen
    Lin, Chin-Hung
    Chen, Jeremy J. W.
    Chen, Kuan-Yu
    Liao, Wei-Yu
    Shih, Jin-Yuan
    Yu, Sung-Liang
    Yu, Chong-Jen
    Yang, Pan-Chyr
    Yang, Tsung-Ying
    Chang, Gee-Chen
    CARCINOGENESIS, 2016, 37 (02) : 157 - 162
  • [27] EGFR co-mutation is associated with the risk of recurrence in invasive lung adenocarcinoma with the micropapillary component
    Kang, Haixin
    Lv, Haiyan
    Tung, Tao-Hsin
    Ma, Dehua
    Wang, Zheng
    Du, Juping
    Zhou, Kai
    Pan, Juan
    Zhang, Yanjie
    Peng, Shuotao
    Yu, Zhaonan
    Shen, Bo
    Ye, Minhua
    ASIAN JOURNAL OF SURGERY, 2024, 47 (01) : 201 - 207
  • [28] Does Tissue EGFR Mutation Status Predict Treatment Response and Mortality in Adenocarcinoma Lung?
    Mohan, Anant
    Dhanuka, Ashutosh
    Ansari, Ashraf
    Masroor, Mirza
    Luthra, Kalpana
    Saxena, Alpana
    Madan, Karan
    Hadda, Vijay
    Khilnani, G.
    Guleria, Randeep
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1209 - S1209
  • [29] Nomogram based on preoperative CT imaging predicts the EGFR mutation status in lung adenocarcinoma
    Zhang, Guojin
    Zhang, Jing
    Cao, Yuntai
    Zhao, Zhiyong
    Li, Shenglin
    Deng, Liangna
    Zhou, Junlin
    TRANSLATIONAL ONCOLOGY, 2021, 14 (01):
  • [30] EGFR MUTATION STATUS IN ADENOCARCINOMA LUNG: A SINGLE CENTRE EXPERIENCE FROM NORTHERN INDIA
    Wadhwa, Jyoti
    Jandya, Sunny
    Batra, Sandeep
    Sharma, Neelam
    Sharma, Devender
    Gupta, Atul
    Puri, Rohit
    Singh, Bhanu P.
    Bali, San-Deep
    Raina, Vimarsh
    Vaid, Ashok K.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S606 - S606
12345